Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy

References

• Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419–4431
   PubMed Web of Science ®Google Scholar
• Miller DJ, Mejicano GC. Vertebral osteomyelitis due to Candida species: case report and literature review. Clin Infect Dis 2001; 33: 523–530
   PubMed Web of Science ®Google Scholar
• Gallagher JC, MacDougall C, Dodds Ashley ES, Perfect JR. Recent advances in antifungal pharmacotherapy for invasive fungal infections. Exp Rev Anti-infective Ther 2004; 2: 253–268
   PubMedGoogle Scholar
• Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38: 161–189
   PubMed Web of Science ®Google Scholar
• Wingard JR. Antifungal chemoprophylaxis after blood and marrow transplantation. Clin Infect Dis 2002; 34: 1386–1390
   PubMed Web of Science ®Google Scholar
• Wingard JR. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis 1994; 19: S49–S53
   PubMed Web of Science ®Google Scholar
• Krcmery V, Barnes AJ. Non-albicans candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243–260
   PubMed Web of Science ®Google Scholar
• Keating GM. Posaconazole. Drugs 2005; 11: 1553–1567
   Google Scholar
• Sabatelli F, Patel R, Mann PA, , et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006; 50: 2009–2015.
   PubMed Web of Science ®Google Scholar
• Tissot-Dupont H, Branger S, Pham T, Blancard A, Lafforgue P. Aspergillus flavus chondrocostal osteomyelitis treated with posaconazole: a case study. Presented at: ECMM/EORTC Joint Meeting; 28 September–1 October 2003; Amsterdam, The Netherlands.
   Google Scholar
• Lodge BA, Ashley ED, Steele MP, Perfect JR. Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole. J Clin Microbiol 2004; 42: 1376–1378
   PubMed Web of Science ®Google Scholar
• Raad II, Graybill JR, Bustamante AB, et al. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis 2006; 42: 1726–1734
   PubMed Web of Science ®Google Scholar
• Kurtzman CP. Descriptions of teleomorphic ascomycetous genera and species. 35. Issatchenkia Kudryavtsev emend. Kurtzman CP, Smiley & Johnson. In: Kurtzman CP, Fell JW. The Yeasts, a Taxonomic Study. Amsterdam: Elsevier, 4th ed, 1999: 221–226.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts: Approved Standard M27-A2, 2nd edn. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002
   Google Scholar
• Frazier DD, Campbell DR, Garvey TA, et al. Fungal infections of the spine: report of eleven patients with long-term follow-up. J Bone Joint Surg Am 2001; 83-A: 560–565.
   Google Scholar
• Nikkanen HE, Brown DFM, Nadel ES. Low back pain. J Emerg Med 2002; 22: 279–283
   PubMed Web of Science ®Google Scholar
• St-Germain G, Laverdiere M, Pelletier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996–1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001; 39: 949–953
   PubMed Web of Science ®Google Scholar
• Peman J, Jarque I, Bosch M, et al. Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns. J Clin Microbiol 2006; 44: 1912–1914
   PubMed Web of Science ®Google Scholar
• Petrikkos G, Skiada A, Sabatakou H, et al. Case report: successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole). Mycoses 2001; 44: 422–425
   PubMed Web of Science ®Google Scholar